<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Autoimmune <z:hpo ids='HP_0000820'>thyroid disease</z:hpo> has been associated with several systemic <z:hpo ids='HP_0002960'>autoimmune disorders</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, limited data are available regarding the prevalence and clinical associations of thyroid <z:hpo ids='HP_0002960'>autoimmunity</z:hpo> in <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="2" pm="."><plain>Seventy-five patients with APS, 75 patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) and 75 healthy controls were tested for the presence of antithyroid antibodies (ATAs) (anti-thyroglobulin and anti-thyroid peroxidase [anti-TPO]) using commercial ELISA </plain></SENT>
<SENT sid="3" pm="."><plain>Clinical data were also recorded </plain></SENT>
<SENT sid="4" pm="."><plain>Although no significant differences in the prevalence of ATAs were detected among APS, SLE patient groups and healthy controls, a significant increase of anti-TPO antibodies in patients with APS-SLE was found </plain></SENT>
<SENT sid="5" pm="."><plain>An increased prevalence of ATAs in APS population with ischemic central <z:mp ids='MP_0008912'>nervous</z:mp> system (<z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>) clinical manifestations was also detected </plain></SENT>
<SENT sid="6" pm="."><plain>We present novel associations between thyroid <z:hpo ids='HP_0002960'>autoimmunity</z:hpo> and ischemic <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> clinical manifestations in the setting of APS </plain></SENT>
</text></document>